Medical Engineering & Physics
Volume 31, Issue 10 , Pages 1205-1213 , December 2009

Evaluation of a bioceramic-based nanocomposite material for controlled delivery of a non-steroidal anti-inflammatory drug

  • S. Hesaraki

      Affiliations

    • Ceramics Department, Materials & Energy Research Center, Tehran 14155/4777, Iran
    • Corresponding Author InformationCorresponding author.
    • ,
  • F. Moztarzadeh

      Affiliations

    • Department of Biomaterials, Faculty of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran
    • ,
  • N. Nezafati

      Affiliations

    • Department of Biomaterials, Faculty of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran

Received 14 January 2009 ,Revised 22 July 2009 ,Accepted 23 July 2009.

References 

  1. Ragel CV, Vallet-Regí M. In vitro bioactivity and gentamicin release from glass–polymer–antibiotic composites. J Biomed Mater Res. 2000;51:424–429
  2. Arcos D, Ragel CV, Vallet-Regí M. Bioactivity in glass/PMMA composites used as drug delivery system. Biomaterials. 2001;22:701–708
  3. Zhang JX, Li XJ, Qiu LY, Li XH, Yan MQ, Yi Jin , et al. Indomethacin-loaded polymeric nanocarriers based on amphiphilic polyphosphazenes with poly (N-isopropylacrylamide) and ethyl tryptophan as side groups: preparation, in vitro and in vivo evaluation. J Control Release. 2006;116:322–329
  4. Cai X, Yang L, Zhang LM, Wu Q. Synthesis and anaerobic biodegradation of indomethacin-conjugated cellulose ethers used for colon-specific drug delivery. Bioresour Technol. 2009;100:4164–4170
  5. Corry D, Moran J. Assessment of acrylic bone cement as a local delivery vehicle for the application of non-steroidal anti-inflammatory drugs. Biomaterials. 1998;19:1295–1301
  6. Hesaraki S, Nemati R, Nosoudi N. Preparation and characterization of porous calcium phosphate bone cement as antibiotic carrier. Adv Appl Ceram. 2009;108:231–240
  7. Santin M, Motta A, Borzachiello A, Nicolais L, Ambrosio L. Effect of PMMA cement radical polymerisation on the inflammatory response. J Mater Sci Mater Med. 2004;15:1175–1180
  8. Otsuka M, Nakahigashi Y, Matsuda Y, Fox JL, Higuchi WI, Sugiyama Y. Effect of geometrical cement size on in vitro and in vivo indomethacin release from self-setting apatite cement. J Control Release. 1998;52:281–289
  9. Yuasa T, Miyamoto Y, Ishikawa K, Takechi M, Nagayama M, Suzuki K. In vitro resorption of three apatite cements with osteoclasts. J Biomed Mater Res. 2001;54:344–350
  10. Costantino PD, Friedman CD, Jones K, Chow LC, Sisson GA. Experimental hydroxyapatite cement cranioplasty. Plast Reconstr Surg. 1992;90:174–191
  11. Krisanapiboon A, Buranapanitkit B, Oungbho K. Biocompatability of hydroxyapatite composite as a local drug delivery system. J Orthop Surg (Hong Kong). 2006;14:315–318
  12. Besson WH. Plaster of Paris as an alloplastic implant in the frontal sinus. Arch Otolaryngol Head Neck Surg. 1981;107:664–669
  13. Lee GH, Khoury JG, Bell JE, Buckwalter JA. Adverse reactions to OsteoSet bone graft substitute, the incidence in a consecutive series. Iowa Orthop J. 2002;22:35–38
  14. Robinson D, Alk D, Sandbank J, Farber R, Halperin N. Inflammatory reactions associated with a calcium sulfate bone substitute. Ann Transplant. 1999;4:91–97
  15. Rauschmann MA, Wichelhaus TA, Stirnal V, Dingeldein E, Zichner L, Schnettler R, et al. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials. 2005;26:2677–2684
  16. Doadrio JC, Arcos D, Cabanas MV, Vallet-Regi M. Calcium sulphate-based cements containing cephalexin. Biomaterials. 2004;25:2629–2635
  17. Englert C, Angele P, Fierlbeck J, Dendorfer S, Schubert T, Müller R, et al. Conductive bone substitute material with variable antibiotic delivery. Unfallchirurg. 2007;110:408–413
  18. Rey C, Combes C, Drouet C, Sfihi H, Barroug A. Physico-chemical properties of nanocrystalline apatites: implications for biominerals and biomaterials. Mater Sci Eng C. 2007;27:198–205
  19. Dorozhkina EI, Dorozhkin SV. Structure and properties of the precipitates formed from condensed solutions of the revised simulated body fluid. J Biomed Mater Res A. 2003;67:578–581
  20. Hesaraki S, Zamanian A, Moztarzadeh F. Effect of adding sodium hexametaphosphate liquefier on basic properties of calcium phosphate cements. J Biomed Mater Res A. 2009;88:314–321
  21. Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro TJ. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res. 1990;24:721–734
  22. Fini G, Fazio G, Feroci G. Solubility and solubilization properties of NSAIDs. Int J Pharm. 1995;126:95–102
  23. Tamimi F, Torres J, Bettini R, Ruggera F, Rueda C, López-Ponce M, et al. Doxycycline sustained release from brushite cements for the treatment of periodontal diseases. J Biomed Mater Res A. 2008;85:707–714
  24. Gbureck U, Vorndran E, Müller FA, Barralet JE. Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices. J Control Release. 2007;122:173–180
  25. Hesaraki S, Nemati R. Cephalexin-loaded injectable macroporous calcium phosphate bone cement. J Biomed Mater Res B (Appl Biomater). 2009;89:342–352
  26. Mao C, Li H, Cui F, Ma C, Feng Q. Oriented growth of phosphates on polycrystalline titanium in a process mimicking biomineralization. J Cryst Growth. 1999;206:308–321
  27. Gitelis S, Piasecki P, Turner T, Haggard W, Charters J, Urban R. Preliminary report: use of a calcium sulfate-based bone graft—substitute for benign bone lesions. Orthopedics. 2001;24:162–166
  28. Kelly CM, Wilkins RM, Gitelis S, Hartjen C, Watson JT, Kim PT. The use of a surgical grade calcium sulfate as a bone graft substitute. Clin Orthop. 2001;382:44–50
  29. Lokaler SA. Antibiotikumtrager aus Kalziumsulfat: Verträ glichkeit im Gewebe und Pharmakokinetik der angewendeten Antibiotika nach Implantation in Kaninchen. Biomaterialien in der Medizin. Giessen: Kohler; 1999;p. 105–8
  30. Hesaraki S, Moztarzadeh F, Solati-Hashjin M. Phase evaluation of an effervescent-added apatitic calcium phosphate bone cement. J Biomed Mater Res B (Appl Biomater). 2006;79:203–209
  31. Du C, Klasens P, Haan RE, Bezemer J, Cui FZ, de Groot K, et al. Biomimetic calcium phosphate coatings on Polyactive 1000/70/30. J Biomed Mater Res. 2002;59:535–546
  32. Landi E, Tampieri A, Celotti G, Langenati R, Sandri M, Sprio S. Nucleation of biomimetic apatite in synthetic body fluids: dense and porous scaffold development. Biomaterials. 2005;26:2835–2845
  33. O’Brien M, McCauley J, Cohen E. Analytical profiles of drug substances. Indomethacin. 1984;13:p.21–234
  34. Hesaraki S, Moztarzadeh F, Solati-Hashjin M. Phase evaluation of an effervescent-added apatitic calcium phosphate bone cement. J Biomed Mater Res B (Appl Biomater). 2006;79B:203–209
  35. Lacout JL, Freche M, Goncalves S, Rodriguez F. Method for preparing a calcium phosphate pasty material for injection; 2005, US Pat 6,923,989.
  36. Heini PF, Berlemann U, Kaufmann M, Lippuner K, Fankhauser C, van Landuyt P. Augmentation of mechanical properties in osteoporotic vertebral bones—a biomechanical investigation of vertebroplasty efficacy with different bone cements. Eur Spine J. 2001;10:164–171
  37. Bohner M, Baroud G. Injectability of calcium phosphate pastes. Biomaterials. 2005;26:1553–1563
  38. Otsuka M, Matsuda Y, Wang Z, Fox JL, Higuchi WI. Effect of sodium bicarbonate amount on in vitro indomethacin release from self-setting carbonated-apatite cement. Pharm Res. 1997;14:444–449
  39. Kosmidis K, Rinaki E, Argyrakis P, Macheras P. Analysis of Case II drug transport with radial and axial release from cylinders. Int J Pharm. 2003;254:183–188

PII: S1350-4533(09)00162-3

doi: 10.1016/j.medengphy.2009.07.019

Medical Engineering & Physics
Volume 31, Issue 10 , Pages 1205-1213 , December 2009

Article Tools

* Image Usage & Resolution